Shares of Chemed Corp. (NYSE:CHE) gapped up prior to trading on Friday . The stock had previously closed at $134.61, but opened at $135.26. Chemed Corp. shares last traded at $137.33, with a volume of 15,166 shares.

A number of analysts have recently commented on CHE shares. Oppenheimer Holdings Inc. reiterated a “buy” rating on shares of Chemed Corp. in a research note on Saturday, April 30th. Zacks Investment Research upgraded shares of Chemed Corp. from a “sell” rating to a “hold” rating in a research note on Tuesday, April 19th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and issued a $136.00 price target (up from $135.00) on shares of Chemed Corp. in a research note on Monday, May 2nd.

The stock has a 50-day moving average price of $132.63 and a 200-day moving average price of $134.87. The firm has a market cap of $2.28 billion and a P/E ratio of 21.54.

Chemed Corp. (NYSE:CHE) last released its quarterly earnings data on Thursday, April 28th. The company reported $1.62 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.58 by $0.04. The business earned $390.40 million during the quarter, compared to analysts’ expectations of $391.68 million. During the same period last year, the company earned $1.54 earnings per share. The firm’s revenue was up 3.6% compared to the same quarter last year. On average, analysts expect that Chemed Corp. will post $7.18 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 15th. Investors of record on Thursday, May 26th were paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend was Tuesday, May 24th.

Other hedge funds have recently added to or reduced their stakes in the company. Comerica Bank raised its stake in Chemed Corp. by 0.4% in the fourth quarter. Comerica Bank now owns 17,174 shares of the company’s stock valued at $2,426,000 after buying an additional 63 shares during the last quarter. State Board of Administration of Florida Retirement System raised its stake in Chemed Corp. by 0.8% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 9,698 shares of the company’s stock valued at $1,453,000 after buying an additional 74 shares during the last quarter. California Public Employees Retirement System raised its stake in Chemed Corp. by 0.4% in the fourth quarter. California Public Employees Retirement System now owns 89,500 shares of the company’s stock valued at $13,407,000 after buying an additional 400 shares during the last quarter. California State Teachers Retirement System raised its stake in Chemed Corp. by 1.3% in the fourth quarter. California State Teachers Retirement System now owns 31,601 shares of the company’s stock valued at $4,734,000 after buying an additional 412 shares during the last quarter. Finally, New York State Common Retirement Fund raised its stake in Chemed Corp. by 5.1% in the fourth quarter. New York State Common Retirement Fund now owns 16,400 shares of the company’s stock valued at $2,457,000 after buying an additional 800 shares during the last quarter.

Chemed Corporation (Chemed) purchases, operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.